a patient reports abdominal cramping after enema administration what action should the nurse take to relieve the discomfort

ATI RN

ATI Capstone Medical Surgical Assessment 2 Quizlet

1. A patient reports abdominal cramping after enema administration. What action should the nurse take to relieve the discomfort?

A. Lower the height of the solution container
B. Increase the flow of enema solution
C. Remove the enema tubing
D. Stop the procedure

Correct answer: A

Rationale: The correct action to relieve abdominal cramping after enema administration is to lower the height of the solution container. This adjustment slows down the flow rate of the enema solution, which can help reduce discomfort by decreasing the pressure on the patient's abdomen. Increasing the flow of the enema solution (Choice B) would exacerbate the cramping by introducing more solution quickly. Removing the enema tubing (Choice C) is not necessary to address the cramping, and stopping the procedure (Choice D) may not be needed if adjusting the height of the solution container can resolve the issue.

2. What is an escharotomy and when is it performed?

A. A surgical incision to release pressure in burn injuries
B. A procedure to remove dead tissue from wounds
C. An incision to improve circulation in tight skin after burns
D. A procedure to remove excess fluid from the chest

Correct answer: A

Rationale: An escharotomy is a surgical incision made to release pressure in a part of the body that has a deep burn and excessive swelling. This procedure is crucial in preventing further damage due to restricted blood flow and compromised circulation. Choice B is incorrect because it describes debridement, which is the removal of dead tissue from wounds. Choice C is incorrect as it does not specifically address the purpose of relieving pressure in burn injuries. Choice D is incorrect as it describes a procedure more related to thoracentesis, which is the removal of excess fluid from the chest, typically the pleural space.

3. A patient experiencing wheezing due to an allergic reaction needs immediate treatment. Which medication should be administered first?

A. Albuterol via nebulizer
B. Cromolyn via nebulizer
C. Aminophylline IV
D. Methylprednisolone IV

Correct answer: A

Rationale: The correct answer is A: Albuterol via nebulizer. Albuterol is a rapid-acting bronchodilator that helps relieve wheezing by opening up the airways. During an allergic reaction causing wheezing, prompt relief is crucial, making Albuterol the first-line treatment. Choice B, Cromolyn via nebulizer, is used more for preventing asthma symptoms rather than providing immediate relief. Choice C, Aminophylline IV, is a bronchodilator with a slower onset of action compared to Albuterol. Choice D, Methylprednisolone IV, is a corticosteroid used to reduce inflammation and is not the first-line treatment for acute wheezing in an allergic reaction.

4. What adverse effect might occur in a patient receiving radiation after a mastectomy?

A. Seizures
B. JVD and fatigue
C. SOB and JVD
D. S3 heart sound

Correct answer: D

Rationale: The correct adverse effect that might occur in a patient receiving radiation after a mastectomy is the development of an S3 heart sound. This can result from decreased pumping ability following mastectomy and radiation treatment. Choice A, seizures, is incorrect as seizures are not a common adverse effect of radiation after a mastectomy. Choice B, JVD and fatigue, is incorrect as while fatigue can be a common side effect, JVD (Jugular Venous Distention) is not typically associated with radiation after a mastectomy. Choice C, SOB (Shortness of Breath) and JVD, is incorrect as while shortness of breath can occur, JVD is not a typical adverse effect of radiation post-mastectomy.

5. What are the priority lab values to monitor in a patient with HIV?

A. CD4 T-cell count below 180 cells/mm3
B. White blood cell count
C. Hemoglobin levels
D. Serum albumin levels

Correct answer: A

Rationale: The correct answer is A: CD4 T-cell count below 180 cells/mm3. Monitoring the CD4 T-cell count is crucial in patients with HIV as it indicates the level of immunocompromise. A CD4 count below 180 cells/mm3 is considered severe immunocompromise and requires close monitoring and intervention. Choices B, C, and D are not the priority lab values to monitor in HIV patients. While white blood cell count, hemoglobin levels, and serum albumin levels can provide valuable information about the patient's health status, they are not as specific or indicative of HIV disease progression and management as the CD4 T-cell count.